Search Count: 44
 |
Erap1 In Complex With (3S,4S)-1-(3-Cyano-6-Methylpyridin-2-Yl)-4-(Propan-2-Yl)Pyrrolidine-3-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-07-08 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVC |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-07-08
Ligands: ZN, PO4, EDO, A1JVC
 |
Erap1 In Complex With (3R,4R)-1-(3-Cyano-6-Methylpyridin-2-Yl)-4-(Propan-2-Yl)Pyrrolidine-3-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2026-07-08 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-07-08
Ligands: ZN, PO4, EDO, A1JVB
 |
Erap1 In Complex With (3R,4R)-1-[3-Cyano-6-(Cyclopropylamino)Pyridin-2-Yl]-4-(Propan-2-Yl)Pyrrolidine-3-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-07-08 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-07-08
Ligands: ZN, PO4, EDO, A1JVL
 |
Erap1 In Complex With (3R,4R)-1-{3-Cyano-4-Methyl-6-[(4-Methyloxan-4-Yl)Amino]Pyridin-2-Yl}-4-(Propan-2-Yl)Pyrrolidine-3-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2026-07-08 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JV2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-07-08
Ligands: ZN, PO4, EDO, A1JV2
 |
Erap1 In Complex With 1-[2-(5-Bromo-7-Fluoro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-06 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, SIN, PO4, EDO, A1JVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-06
Ligands: ZN, SIN, PO4, EDO, A1JVE
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVD
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, MLT, EDO, A1JVG
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVH
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVF
 |
Erap1 In Complex With 1-[2-(3-Oxo-3,4-Dihydro-2H-1,4-Benzothiazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, B3P, EDO, BR, A1IMK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, B3P, EDO, BR, A1IMK
 |
Erap1 In Complex With 1-[2-(6-Bromo-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1IMJ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, PO4, EDO, A1IMJ
 |
Erap1 In Complex With 1-[2-(6-Chloro-3-Oxo-3,4-Dihydro-2H-1,4-Benzothiazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1IMM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, MLT, EDO, A1IMM
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1IML |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, PO4, EDO, A1IML
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Ethane-1,2-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-11-08 Classification: TRANSCRIPTION Ligands: EDO, ZTT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-11-08
Ligands: EDO, ZTT
 |
C-Terminal Bromodomain Of Human Brd2 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: NUB, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: NUB, MES
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-5-(1-((1-Acetylpiperidin-3-Yl)Methyl)-5-Bromo-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: EDO, MES, I0U |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: EDO, MES, I0U
 |
N-Terminal Bromodomain Of Human Brd4 With (S)-5-(1-((1-(1-Isopropylpiperidine-4-Carbonyl)Piperidin-3-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: I0Z |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: I0Z
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Pentane-1,5-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2023-10-04 Classification: TRANSCRIPTION Ligands: ZTY, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-04
Ligands: ZTY, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: 80Z, EDO, PE4
 |
Bromodomain Of Human Taf1 (2) With Naphthyridinone Compound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2021-10-13 Classification: TRANSCRIPTION Ligands: 5LV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: 5LV